Pharmaceutical Manufacturing Waste Recovery
Recover complex and expensive novel compounds from experiments and regulatory compliance activity.
Pilot, Demonstration, and & Validation batch, and Non-spec material can contain valuable material that can be recovered.
In 2019, the worlds top 15 pharmaceutical companies produced 500 million kilograms of waste though manufacturing processes. The waste can be categorised into different sub-categories including: API discharge, unrecoverable solvents, packaging, and non-spec material.
The inefficient use of material costs the industry over $50 billion annually.
The disposal of the waste costs an additional $3 billion.
UnBound Chemicals is developing the technology and equipment to efficiently rework pharmaceutical waste back into reusable raw materials, building blocks, intermediaries and active ingredients.